Neurological Surgery

Publications

Found 45 results

Author Title [ Type

] Year

Filters: Author is Ramakrishna, Rohan [Clear All Filters]

Journal Article

Bander ED, Shelkov E, Modik O, Kandula P, Karceski SC, Ramakrishna R. 2020. Use of the train-of-five bipolar technique to provide reliable, spatially accurate motor cortex identification in asleep patients.. Neurosurg Focus. 48(2):E4.

Pine AR, Cirigliano SM, Nicholson JG, Hu Y, Linkous A, Miyaguchi K, Edwards L, Singhania R, Schwartz TH, Ramakrishna R et al.. 2020. Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas.. Cancer Discov. 10(7):964-979.

Bander ED, Jones SH, Pisapia D, Magge R, Fine H, Schwartz TH, Ramakrishna R. 2019. Tubular brain tumor biopsy improves diagnostic yield for subcortical lesions.. J Neurooncol. 141(1):121-129.

Ramakrishna R, Kim LJ, Bly RA, Moe K, Ferreira M. 2016. Transorbital neuroendoscopic surgery for the treatment of skull base lesions.. J Clin Neurosci. 24:99-104.

O'Brien DARoth, Poppas P, Kaye SM, Mahase SS, An A, Christos PJ, Liechty B, Pisapia D, Ramakrishna R, A Wernicke G et al.. 2021. Timing of Adjuvant Fractionated Stereotactic Radiosurgery Impacts Local Control of Resected Brain Metastases.. Pract Radiat Oncol.

Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I. 2019. Texture analysis on conventional MRI images accurately predicts early malignant transformation of low-grade gliomas.. Eur Radiol. 29(6):2751-2759.

Ramakrishna R, Hsu W-C, Mao J, Sedrakyan A. 2018. Surgeon Annual and Cumulative Volumes Predict Early Postoperative Outcomes After Brain Tumor Resection.. World Neurosurg. 114:e254-e266.

Roytman M, Pisapia DJ, Liechty B, Lin E, Skafida M, Magge RS, Osborne JR, Pannullo SC, Knisely JPS, Ramakrishna R et al.. 2020. Somatostatin receptor-2 negative meningioma: pathologic correlation and imaging implications.. Clin Imaging. 66:18-22.

Bander ED, Kelly A, Ma X, Christos PJ, A Wernicke G, Stieg PE, Trichter S, Knisely JPS, Ramakrishna R, Schwartz TH. 2023. Safety and efficacy of Cesium-131 brachytherapy for brain tumors.. J Neurooncol. 163(2):355-365.

Uppstrom TJ, Singh R, Hadjigeorgiou GF, Magge R, Ramakrishna R. 2016. Repeat surgery for recurrent low-grade gliomas should be standard of care.. Clin Neurol Neurosurg. 151:18-23.

Younus I, Gerges MM, Dobri GA, Ramakrishna R, Schwartz TH. 2019. Readmission after endoscopic transsphenoidal pituitary surgery: analysis of 584 consecutive cases.. J Neurosurg. :1-6.

Ramakrishna R, Formenti S. 2019. Radiosurgery and Immunotherapy in the Treatment of Brain Metastases.. World Neurosurg. 130:615-622.

Safi C, Li C, Tabaee A, Ramakrishna R, Riley CA. 2019. Outcomes and imaging findings of respiratory epithelial adenomatoid hamartoma: a systematic review.. Int Forum Allergy Rhinol. 9(6):674-680.

Nassiri F, Patil V, Yefet LS, Singh O, Liu J, Dang RMA, Yamaguchi TN, Daras M, Cloughesy TF, Colman H et al.. 2023. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.. Nat Med.

Pham A, Yondorf MZ, Parashar B, Scheff RJ, Pannullo SC, Ramakrishna R, Stieg PE, Schwartz TH, A Wernicke G. 2016. Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial.. J Neurooncol. 127(1):63-71.

Chidambaram S, Winston GM, Knisely JPS, Ramakrishna R, Juthani R, Salah K, McKenna JT, Jozsef G, Cardona D, Pannullo SC. 2019. A Multidisciplinary Team Approach to Brain and Spine Stereotactic Radiosurgery Conferences: A Unique Institutional Model.. World Neurosurg. 131:159-162.

Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC. 2019. MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.

Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I. 2019. MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.

Ramos AD, Magge RS, Ramakrishna R. 2018. Molecular Pathogenesis and Emerging Treatment for Glioblastoma.. World Neurosurg. 116:495-504.

Chiang GC, Kovanlikaya I, Choi C, Ramakrishna R, Magge R, Shungu DC. 2018. Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.. Front Neurol. 9:33.

Knisely JPS, Ramakrishna R, Schwartz TH. 2018. Letter to the Editor. How safe, really, is jugular paraganglioma radiosurgery? J Neurosurg. :1-3.

Ramakrishna R, Zadeh G, Sheehan JP, Aghi MK. 2020. Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.. J Neurooncol.

Younus I, Gerges MM, Godil SS, Uribe-Cardenas R, Dobri GA, Ramakrishna R, Schwartz TH. 2019. Incidence and risk factors associated with reoperation for sellar hematoma following endoscopic transsphenoidal pituitary surgery.. J Neurosurg. :1-7.

Pisapia DJ, Magge R, Ramakrishna R. 2017. Improved Pathologic Diagnosis-Forecasting the Future in Glioblastoma.. Front Neurol. 8:707.

Younus I, Gerges M, Schwartz TH, Ramakrishna R. 2020. Impact of Medicaid insurance on outcomes following endoscopic transsphenoidal pituitary surgery.. J Neurosurg. :1-6.